MedTrace Logo

The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism

NCT05820256 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-12-06

No results posted yet for this study

Summary

Dairy products provide macronutrients, vitamins, and minerals that are important for health and development. Despite this, many Canadians now eat fewer dairy products and are instead consuming more non-dairy alternatives, such as soy. Some of this is because of misconceptions about the effects of dairy on health. However, the study investigators hypothesize that, compared to soy, dairy may actually improve a person's health due to its effects on the enzymes in the body that make omega-3 fatty acids, such as EPA and DHA. The goal of this study is to examine omega-3 metabolism in men and women consuming either milk or soy protein. Briefly, this study will determine if the consumption of milk or soy protein differentially impacts blood EPA and DHA levels, the synthesis of EPA and DHA, fatty acid oxidation, and omega-3 fat absorption from the gut. It is anticipated that the findings from this novel and innovative research project will provide high quality evidence to support a previously unappreciated protective effect of dairy for human health and development.

Conditions

  • Nutrition, Healthy

Interventions

DIETARY_SUPPLEMENT

Milk Protein Isolate (MPI)

Study participants will consume two smoothies per day containing a milk protein isolate (MPI) for 31 days.

DIETARY_SUPPLEMENT

Soy Protein Isolate (SPI)

Study participants will consume two smoothies per day containing a soy protein isolate (SPI) for 31 days.

Sponsors & Collaborators

  • Université de Sherbrooke

    collaborator OTHER

  • University of Guelph

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-18
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820256 on ClinicalTrials.gov